Covid-19 vaccine hopes raised as trial of Moderna’s experimental jab shows ALL 45 injected volunteers developed antibodies
- Moderna’s coronavirus vaccine candidate has completed its phase 1 human trial
- Tests found the virus triggered immune responses, measured by antibody levels
- More than half of trial participants had mild reactions like fatigue and headaches
- Moderna’s experimental Covid-19 jab was the first to enter human trials in the US
Hopes of getting a Covid-19 vaccine were raised today after Moderna’s experimental jab was proven to trigger an immune response in all 45 injected volunteers.
Researchers also found the jab — one of the front-runners in the global coronavirus vaccine race — was safe and no participants suffered any serious side effects.
But more than half reported mild or moderate reactions such as fatigue, headache, chills, muscle aches or pain at the injection site. Scientists said side effects were a ‘small price to pay’ for protection against Covid-19.
This article was originally published on MailOnline.
Author: Various
COVID-19 articles sourced from various authors.
